Obesity Clinical Trial
— ENDOFITOfficial title:
Effect of Endurance and Endurance-Strength Training on Inflammatory Markers in Women With Abdominal Obesity
Verified date | February 2018 |
Source | Poznan University of Medical Sciences |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The aim of this study was to compare the effects of three months' endurance training and three months' endurance-strength training on inflammatory markers in women with abdominal obesity.
Status | Completed |
Enrollment | 38 |
Est. completion date | December 30, 2017 |
Est. primary completion date | December 1, 2017 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 18 Years to 65 Years |
Eligibility |
Inclusion Criteria: - informed written consent; - simple obesity; - age from 18 to 65 years; - body fat content, assessed by electrical bioimpedance, equal to or more than 33%; - waist circumference more than 80 cm; - stable body weight in the one month prior to the trial. Exclusion Criteria: - secondary form of excess body mass - secondary form of arterial hypertension - mean systolic blood pressure > 140 mmHg and/or mean diastolic blood pressure > 90 mmHg; - diabetes; - ischemic heart disease; - stroke; - heart failure; - history of malignancy; - clinically significant heart arrhythmias; - a history of use of any dietary supplement; - serious liver or kidney damage; - abnormal thyroid gland function; - clinically significant inflammation, connective tissue disease, or arthritis; - nicotine, alcohol, or narcotic abuse; - infection; - pregnancy, childbirth, or lactation; - any other condition that would make participation not in the best interest of the subject, or could prevent the efficacy of the study. |
Country | Name | City | State |
---|---|---|---|
Poland | Department of Education and Obesity Treatment and Metabolic Disorders; Poznan University of Medical Sciences | Poznan |
Lead Sponsor | Collaborator |
---|---|
Poznan University of Medical Sciences |
Poland,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | C-reactive protein (CRP) at baseline | Serum concentration of C-reactive protein at baseline | At baseline | |
Primary | CRP after three months of physical training | Serum concentration of C-reactive protein after three months of physical training | after three months of physical training | |
Secondary | tumor necrosis factor alpha (TNFa) at baseline | Serum concentration of tumor necrosis factor alpha at baseline | at baseline | |
Secondary | TNFa after three months of physical training | Serum concentration of tumor necrosis factor alpha after three months of physical training | after three months of physical training | |
Secondary | soluble receptor 2 of TNF alpha (sTNF R2) at baseline | Serum concentration of soluble receptor 2 of TNF alpha at baseline | At baseline | |
Secondary | sTNF R2 after three months of physical training | Serum concentration of soluble receptor 2 of TNF alpha after three months of physical training | after three months of physical training | |
Secondary | interleukin 6 (IL-6) at baseline | Serum concentration of interleukin 6 at baseline | At baseline | |
Secondary | IL-6 after three months of physical training | Serum concentration of interleukin 6 after three months of physical training | after three months of physical training | |
Secondary | interleukin 1 (IL-1) at baseline | Serum concentration of interleukin 1 at baseline | At baseline | |
Secondary | IL-1 after three months of physical training | Serum concentration of interleukin 1 after three months of physical training | after three months of physical training | |
Secondary | visfatin at baseline | Serum concentration of visfatin at baseline | At baseline | |
Secondary | visfatin after three months of physical training | Serum concentration of visfatin after three months of physical training | after three months of physical training | |
Secondary | Body mass at baseline | Body mass at baseline | At baseline | |
Secondary | Body mass after three months of physical training | Body mass after three months of physical training | after three months of physical training | |
Secondary | Body height at baseline | Body height at baseline | At baseline | |
Secondary | Body height after three months of physical training | Body height after three months of physical training | after three months of physical training |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |